Replies to post #43699 on Breakthrough Chemistry Inc (BKTH)

[I ll be back]

That's a GREAT question. LMAO

What do these $MGON team members do for their real day jobs?

Gee, I don't know! You tell me.....I'm guessing you have been hanging around pinks a little long. 😆

Key DD timeline of events showing management isn't holding back!

With the name changed approval (as noted by Fidelity) the OTCQB is NOW close at hand in order to fund the ramp up with Winner, assuming it is even needed.

Funding for production, IF NEEDED:
On May 7, 2024, the Company filed a Registration Statement on Form 1-A with the Securities and Exchange Commission (“SEC”) with respect to the offering of a total of 400,000,000 shares of Common Stock at $0.025 per share for total gross proceeds of up to $10,000,000 (the “Offering”). The Offering received notice of qualification from the SEC on June 12, 2024. The Company has not yet sold any shares under this Offering.

Patent Application:
On June 25, 2024, the Company’s technology licensor, MedeSol Global, Inc., filed a provisional patent application covering various odor control product formats including Porta Potty deodorization. This filing is included in the existing license agreement, furthering the Company’s broad intellectual property portfolio.

Audited Financials:
On August 12, 2024 the Company “audited” financial statements filed with the Securities and Exchange Commission.

Breakthrough Chemistry name change:
On September 12, 2024, the Company executed an Amendment to its Articles of Incorporation with the Secretary of State of Nevada, changing the name of the Company to Breakthrough Chemistry, Inc., having received Board and Majority Shareholder approval.

Four months for approval by FINRA:
On September 19, 2024, the Company filed a Corporate Action with FINRA for an OTC Voluntary Name and Symbol Change to Breakthrough Chemistry, Inc., which was still pending as of the filing date of this report.

Additional team members:
On November 19, 2024, the Company added Paul Cohen and Darryl Campbell as independent members to its Board of Directors and approved an Audit Committee Charter. They will both join the Audit Committee along with existing board member Mark Suchy. The three Audit Committee members bring many years of business experience and have the required financial acumen required to serve on the Audit Committee.

Uplisting filed:
On November 19, 2024, the Company applied for admission to the OTCQB Venture Market. Admission to OTCQB is contingent on a review by OTC Markets.

On December 9, 2024:
Winner Medical has completed manufacturing the incontinence diaper prototypes for human wear testing, which is now being initiated.

FINRA approval:
On December 31, 2024, Team post on X:
1-SA filed! Confident FINRA is nearing a decision on N&S after addressing multiple corporate inquires. Progress continues on OTCQB uplist.

On January 8, 2025, Fidelity shows the first name change filing with Breakthrough Chemistry.

Link for those trying to get up to speed before this rocket takes off with a Winner update:
https://www.sec.gov/Archives/edgar/data/1144392/000147793224008377/mgon_1sa.htm

[One11]

One day, you may get a real job! Then it won't be so foreign of an idea that people make stuff happen. Until then, it's time to make your bed and take out the garbage. Don't forget to reset those mouse traps in the basement.